Director KYC, DIN and Board Composition

Quick View

Why It Matters

DIN, annual KYC and contact details should remain current under MCA requirements. Deactivation or outdated information can disrupt filings and signal weak governance.

Appointments and cessations require consent, declarations, board or shareholder action and filings as applicable. The company should verify disqualification, interests and other directorships.

Board composition should be tested against the Companies Act, articles, investor rights and sector requirements. Nominee status does not remove fiduciary duties.

Control Framework

Action Checklist

1. Maintain a director master register.
2. Track annual KYC completion.
3. Obtain consent and eligibility documents.
4. Review board composition before appointments.
5. File changes promptly.
6. Refresh conflict declarations periodically.

Practical Example

Evidence to Keep

• DIN and KYC acknowledgements.
• Consent and declarations.
• Appointment and cessation minutes.
• MCA filings and SRNs.
• Interest and directorship disclosures.
• Board composition review.

Warning Signs

Management Decision

Use a governance dashboard showing each director’s term, KYC, signature status, committees, conflicts and pending filings.

Before a financing or major approval, confirm that the board is lawfully constituted and every participating director can act.

Record the decision, owner, due date and evidence expected. A verbal explanation should become an approved working, board note, contract amendment, statutory filing or reconciliation before the item is treated as closed.

Rules, forms, thresholds and procedures can change. Use the latest official source and the actual company facts rather than copying a prior-year control or another entity’s legal position.

Exception Review

Classify every exception as a timing difference, data error, missing document, legal non-compliance, control-design gap or control-operating failure. This prevents management from treating fundamentally different problems as one ageing list.

The exception file should show amount or exposure, root cause, immediate correction, preventive action, owner and board-escalation threshold. Repeated low-value issues can become material when they reveal weak systems or management override.

Close the item only after the evidence agrees across source documents, books, portal data and management reporting. A screenshot or email promise is not equivalent to a completed filing, lender waiver, signed contract or reconciled ledger.

Board Escalation

The control should operate across the full transaction population, not only the samples management expects a reviewer to inspect. For this topic, the key stages are identity, eligibility, composition, interests. Each stage should identify the source system, preparer, reviewer, deadline and evidence retained.

A useful management review asks whether the legal document, accounting entry, bank movement, tax treatment and public filing describe the same event. Differences may be valid, but they should be reconciled through a dated working rather than explained from memory during audit or diligence.

Materiality should determine escalation, not whether the company keeps a record. Repeated small exceptions can show weak master data, unclear authority, system bypass or management override. Root cause and preventive action should therefore be documented separately from the immediate correction.

Corporate action should follow the correct sequence: authority, offer or decision, execution, money or asset movement, filing, statutory-register update and public-record verification. Reversing the sequence can create a transaction that is commercially agreed but legally incomplete.

Before any fundraising, restructuring or lender diligence, compare the articles, shareholders’ agreement, board records, statutory registers and MCA data. A mismatch in ownership, director authority or charge status should be escalated before closing documents are signed.